Sarcopenia is typically a condition of older people. One US study found sarcopenia to be common in adults over 65 years of age and the prevalence to increase with age.[4]Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M772-7.
https://academic.oup.com/biomedgerontology/article/57/12/M772/688560
http://www.ncbi.nlm.nih.gov/pubmed/12456735?tool=bestpractice.com
The prevalence of sarcopenia in the cohort studied was 22.6% in women and 26.8% in men. In a subgroup analysis of women and men aged 80 years or older, the prevalence was 31.0% and 52.9%, respectively.[4]Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M772-7.
https://academic.oup.com/biomedgerontology/article/57/12/M772/688560
http://www.ncbi.nlm.nih.gov/pubmed/12456735?tool=bestpractice.com
Another study found that the prevalence of sarcopenia increased from 4% of men and 3% of women aged 70-75 years to 16% of men and 13% of women aged 85 years and older in a study of 694 men and 1006 women aged over 55 years.[5]Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, et al. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2003 Oct;25(3):226-31.
http://www.ncbi.nlm.nih.gov/pubmed/14507529?tool=bestpractice.com
The Asian Working Group for Sarcopenia reported the prevalence of sarcopenia based on a review of Asian studies to be 5.5% to 25.7%, with a range of 5.1% to 21.0% in men versus 4.1% to 16.3% in women.[6]Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-7.
http://www.ncbi.nlm.nih.gov/pubmed/32033882?tool=bestpractice.com
In Europe, the prevalence of sarcopenia in older people is predicted to increase from 11% as of 2016 to an estimated 13% by 2045.[7]Ethgen O, Beaudart C, Buckinx F, et al. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int. 2017 Mar;100(3):229-34.
https://link.springer.com/article/10.1007/s00223-016-0220-9
http://www.ncbi.nlm.nih.gov/pubmed/28012107?tool=bestpractice.com
International studies, using data up to 2021, reported a global prevalence of 10% to 27% in people over age 60 years.[8]Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):86-99.
https://onlinelibrary.wiley.com/doi/10.1002/jcsm.12783
http://www.ncbi.nlm.nih.gov/pubmed/34816624?tool=bestpractice.com